Recent News

• 03.07.2025 - Q4 2024 Lifeward, Inc. Earnings Conference Call
• 03.06.2025 - Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
• 03.05.2025 - Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
• 02.20.2025 - Lifeward Investor Event
• 02.19.2025 - Lifeward Announces CEO Transition
• 02.05.2025 - Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany
• 02.04.2025 - Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025
• 02.04.2025 - Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025
• 01.13.2025 - Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities
• 01.13.2025 - Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Recent Filings

• 02.20.2025 - 8-K Current report
• 02.14.2025 - EFFECT Notice of Effectiveness
• 02.14.2025 - S-1/A General form for registration of securities under the Securities Act of 1933
• 02.11.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 01.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.13.2025 - 8-K Current report
• 01.13.2025 - EX-99.1 EX-99.1
• 01.13.2025 - D Notice of Exempt Offering of Securities